ANVS
ANVS
NYSE · Biotechnology

Annovis Bio

$1.18
+0.01 (+0.85%)
As of Oct 3, 2:34 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,125.4% upside
Low Target $8.98
Average Target $14.46
High Target $17.59
Current Price $1.18
Current
$1.18
Target
$14.46
$8.98 $14.46 avg $17.59
Scenario Analysis
Bear Case
$8.98
661.0%
Low target
Base Case
$14.46
+1,125.4%
Avg target
Bull Case
$17.59
+1,390.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$5.50
-78.5% from high
52-Week Low
$1.04
+13.5% from low
Target vs 52W High
$14.46
+162.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.0%
AMGN
Amgen Inc
Hold 43 47% $190.87 -52.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +150.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -13.2%
MRNA
Moderna Inc
Hold 30 37% $149.45 -21.3%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.8%